| __timestamp | Alnylam Pharmaceuticals, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 190249000 | 79838000 |
| Thursday, January 1, 2015 | 276495000 | 121816000 |
| Friday, January 1, 2016 | 382392000 | 117633000 |
| Sunday, January 1, 2017 | 390635000 | 117456000 |
| Monday, January 1, 2018 | 505420000 | 171984000 |
| Tuesday, January 1, 2019 | 655114000 | 257452000 |
| Wednesday, January 1, 2020 | 654819000 | 477643000 |
| Friday, January 1, 2021 | 792156000 | 540684000 |
| Saturday, January 1, 2022 | 883015000 | 651496000 |
| Sunday, January 1, 2023 | 1004415000 | 666563000 |
| Monday, January 1, 2024 | 1126232000 |
Cracking the code
In the dynamic world of biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Alnylam Pharmaceuticals, Inc. and PTC Therapeutics, Inc. have been at the forefront of this trend, showcasing significant investment in R&D over the past decade. From 2014 to 2023, Alnylam's R&D expenses surged by over 400%, reflecting its commitment to pioneering RNA interference therapies. Meanwhile, PTC Therapeutics increased its R&D spending by approximately 735%, underscoring its focus on rare genetic disorders. Notably, in 2023, Alnylam allocated nearly 60% more to R&D than PTC, highlighting its aggressive strategy in the competitive biotech landscape. These investments not only drive innovation but also position these companies as leaders in their respective fields, promising groundbreaking advancements in healthcare.
R&D Spending Showdown: Eli Lilly and Company vs PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Pfizer Inc. and PTC Therapeutics, Inc.
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc
Comparing Innovation Spending: Alnylam Pharmaceuticals, Inc. and Axsome Therapeutics, Inc.
Alnylam Pharmaceuticals, Inc. or Wave Life Sciences Ltd.: Who Invests More in Innovation?
Research and Development Investment: Pharming Group N.V. vs PTC Therapeutics, Inc.
R&D Spending Showdown: PTC Therapeutics, Inc. vs Arrowhead Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for PTC Therapeutics, Inc. and Bausch Health Companies Inc.
PTC Therapeutics, Inc. vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for PTC Therapeutics, Inc. and Amphastar Pharmaceuticals, Inc.
PTC Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending